Pharmafile Logo
Pharmafocus logo
Advanced Search

Five capabilities of centered leadership

February 3, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Caroline Webb, Joanna Barsh, Josephine Mogelof, McKinsey & Company, leadership

The business environment has become more demanding: the global financial crisis and subsequent economic downturn have ratcheted up the pressure …

Feature

Pfizer appoints Dr Yvonne Greenstreet to specialty care business

February 3, 2011
Research and Development Dr Yvonne Greenstreet, Pfizer, appointment, specialty care

Dr Yvonne Greenstreet has joined Pfizer to head up medicines development for its Specialty Care business unit. She moves to …

Appointment
Roche Severin Schwann

Roche weathers tough year and looks to pipeline for 2011

February 3, 2011
Research and Development, Sales and Marketing 2010 pharma results, BRAF protein, GDC-0449, RG3616, RG7204, Roche, avastin, pertuzumab

Roche is looking to its innovative late-stage pipeline to help it get back on track for the next financial year …

News

Blood clot fears halt cancer trial enrolment

February 3, 2011
Research and Development BMS, Bristol-Myers Squibb, Eli Lilly, NSCLC, lilly, necitumumab, non small cell lung cancer, non-small cell lung cancer

Lilly and BMS have stopped enrolment in a phase III trial of necitumumab, a new treatment for non-small cell lung …

News

Jango to manage Grünenthal pain awards

February 3, 2011
Medical Communications Grunenthal, Jango, awards, disease awareness campaigns

Jango Communications has been appointed by Grünenthal to manage the Pain Awards Programme they are sponsoring this year. German-based Grünenthal, …

News

The Project Management Office – Accelerating Project Management Maturity

February 3, 2011
Sales and Marketing Kinapse, White paper

Success in the life sciences industry depends on allocation of scarce resource to the right projects at different stages of …

Feature
White paper

Diabetes success for Sanofi, disappointment for Roche

February 2, 2011
Roche, Sanofi, diabetes

The contrasting fortunes of two new diabetes became clear today, with Sanofi-Aventis lixisenatide performing well, as Roche abandoned taspoglutide.Sanofi’s lixisenatide, …

News
Sandwich R&D

Government seeks to salvage Pfizer site

February 2, 2011
Research and Development Pfizer, Sandwich

Science minister David Willetts says the government will do all it can to maintain pharma research in Kent, after Pfizer …

News

Leading universities sound alarm over UK research

February 2, 2011
Research and Development Jobs, Pfizer, Sandwich, universities

Cuts to government funding for research in universities have been condemned by the UK’s top centres of learning. The government …

News
cherry_wood

Cherry Wood new HCA chair

February 1, 2011
Medical Communications Cherry Wood, HCA

The Healthcare Communications Association (HCA) has announced that Cherry Wood, managing director of Liberation Communications, has been elected its new …

Appointment
Pfizer's R&D site in Sandwich, Kent

Pfizer to close UK R&D site

February 1, 2011
Research and Development Kent, Pfizer, R&D, Sandwich, closure

Pfizer has announced that it is to close its UK research site at Sandwich in Kent, with the loss of …

News

GSK settles Avandia case out of court

February 1, 2011
Sales and Marketing Avandia, GSK, diabetes

GlaxoSmithKline this week settled a US federal lawsuit regarding its diabetes drug Avandia before it went to court. The company …

News

FDA process validation guidelines emphasise risk management

February 1, 2011
Manufacturing and Production FDA, ICH, process validation

The FDA has published the final version of its Guideline on Process Validation, more than two years after the first …

News

Sanofi – Genzyme deal edges closer

February 1, 2011
Sales and Marketing Genzyme, Lemtrada, Sanofi

Sanofi-Aventis has entered into a confidentiality agreement with Genzyme to discuss the prospects of Lemtrada, which suggests a deal could …

News

Oxford BioMedica buys decommissioned facility

February 1, 2011
Manufacturing and Production Oxford BioMedica, RecipharmCobra Biologics, manufacturing

Gene therapy specialist Oxford BioMedica has said it plans to acquire a £1.9 million ($3.1m) manufacturing facility from contract manufacturer …

News

Tarceva set for first line treatment

January 31, 2011
Sales and Marketing Iressa, NSCLC, Roche, Tarceva

Roche’s lung cancer treatment Tarceva has been shown to help patients as a first line treatment. An independent data monitoring …

News

UK hails high uptake of cervical cancer vaccine

January 31, 2011
Research and Development Cervarix, HPV

The NHS campaign to vaccinate girls against the future risk of developing cervical cancer has been a success, according to …

News

AstraZeneca revenues reach standstill

January 31, 2011
Sales and Marketing AstraZeneca, Full year 2010, patent expiry, results

AstraZeneca’s revenues came to a virtual standstill in 2010, with strong growth outside the US being offset by generic competition …

News

GSK and Actelion drop insomnia treatment

January 30, 2011
Research and Development Actelion, GSK, insomnia

Actelion and GlaxoSmithKline are to abandon development of phase III insomnia drug almorexant because of problems with side-effects.Almorexant a dual …

News

Mitsubishi Tanabe recalls two million injectables

January 28, 2011
Manufacturing and Production Mitsubishi, injectables, recall

Mitsubishi Tanabe Corp has said it will recall two million of its injectable medicines made at a facility in Ashikaga, …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026